No October surprise here. AbbVie’s Humira is once again the top-spending TV pharma advertiser for the month. However, maybe just a little surprising is that its spending of $39.1 million was up 85% ...
July 27 (Reuters) - AbbVie (ABBV.N), opens new tab on Thursday trimmed its 2023 view for declining sales of its flagship arthritis drug Humira despite new competition, as favorable positions on ...
JERUSALEM, May 8 (Reuters) - Teva Pharmaceutical Industries (TEVA.TA), opens new tab said it was set to launch its long awaited biosimilar of AbbVie's (ABBV.N), opens new tab blockbuster arthritis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback